BioAdaptives, Inc. (BDPT)
OTCMKTS · Delayed Price · Currency is USD
0.0019
+0.0007 (55.74%)
Jul 27, 2026, 2:54 PM EST
BioAdaptives Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.07 | 0.16 | 0.14 | 0.06 | 0.03 | 0.08 |
Short-Term Investments | - | - | - | - | 0 | 0 |
Cash & Short-Term Investments | 0.07 | 0.16 | 0.14 | 0.06 | 0.03 | 0.08 |
Cash Growth | 86.04% | 15.26% | 126.19% | 138.83% | -69.39% | 1552.28% |
Other Receivables | - | - | 0 | - | - | - |
Receivables | - | - | 0 | - | - | - |
Inventory | 0.04 | 0.04 | 0.02 | 0.02 | 0.01 | 0 |
Prepaid Expenses | 0 | 0.01 | 0.1 | 0.01 | - | 0 |
Other Current Assets | 0 | 0 | 0 | 0 | - | - |
Total Current Assets | 0.12 | 0.21 | 0.26 | 0.09 | 0.03 | 0.09 |
Property, Plant & Equipment | 0.01 | 0.01 | - | - | - | - |
Other Intangible Assets | - | - | - | 0.02 | 0 | 0.06 |
Total Assets | 0.14 | 0.23 | 0.26 | 0.1 | 0.04 | 0.15 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.01 | 0.01 | 0.01 | 0 | 0.01 | 0 |
Accrued Expenses | 0.24 | 0.22 | 0.17 | 0.44 | 0.4 | 0.25 |
Short-Term Debt | 0.03 | 0.03 | 0.03 | 0.01 | 0.01 | 0.03 |
Current Portion of Long-Term Debt | 0.42 | 0.35 | 0.46 | 0.32 | 0.38 | 0.4 |
Other Current Liabilities | 1.56 | 1.74 | 1.05 | 0.98 | 0.69 | 0.56 |
Total Current Liabilities | 2.27 | 2.36 | 1.73 | 1.75 | 1.49 | 1.24 |
Total Liabilities | 2.27 | 2.36 | 1.73 | 1.75 | 1.49 | 1.24 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0.03 | 0.01 |
Additional Paid-In Capital | 8.7 | 8.6 | 7.7 | 6.62 | 6.07 | 5.56 |
Retained Earnings | -10.83 | -10.72 | -9.16 | -8.26 | -7.55 | -6.66 |
Comprehensive Income & Other | -0.01 | -0.01 | -0.01 | - | - | - |
Total Common Equity | -2.14 | -2.13 | -1.46 | -1.65 | -1.45 | -1.09 |
Shareholders' Equity | -2.14 | -2.13 | -1.46 | -1.65 | -1.45 | -1.09 |
Total Liabilities & Equity | 0.14 | 0.23 | 0.26 | 0.1 | 0.04 | 0.15 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.46 | 0.38 | 0.49 | 0.33 | 0.39 | 0.44 |
Net Cash (Debt) | -0.38 | -0.23 | -0.36 | -0.27 | -0.37 | -0.35 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.04 | -0.02 | -0.04 | -0.04 | -0.52 | -1.57 |
Filing Date Shares Outstanding | 12.01 | 12.01 | 9.05 | 6.48 | 2.37 | 0.37 |
Total Common Shares Outstanding | 12.01 | 12.01 | 8.22 | 5.97 | 1.68 | 0.34 |
Working Capital | -2.15 | -2.14 | -1.46 | -1.66 | -1.45 | -1.15 |
Book Value Per Share | -0.18 | -0.18 | -0.18 | -0.28 | -0.86 | -3.23 |
Tangible Book Value | -2.14 | -2.13 | -1.46 | -1.66 | -1.45 | -1.15 |
Tangible Book Value Per Share | -0.18 | -0.18 | -0.18 | -0.28 | -0.86 | -3.40 |